Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-013904
Filing Date
2019-02-26
Accepted
2019-02-26 21:42:00
Documents
1
Period of Report
2019-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4105
  Complete submission text file 0001209191-19-013904.txt   5488
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Issuer) CIK: 0001636651 (see all company filings)

EIN.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O OVID THERAPEUTICS INC. 1460 BROADWAY, SUITE 15044 NEW YORK NY 10036
Business Address
During Matthew (Reporting) CIK: 0001704631 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38085 | Film No.: 19635642